Johnson & Johnson Q1 Earnings Smash Expectations—Full-Year Outlook Raised for 2025
Johnson & Johnson Q1 earnings smash expectations—full-year outlook raised for 2025 as the global healthcare giant posted impressive revenue and earnings growth, driven by strong pharmaceutical performance and expansion in…

